
COVID‐19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria
2021; Wiley; Volume: 36; Issue: 1 Linguagem: Inglês
10.1111/jdv.17635
ISSN1468-3083
AutoresPaulo Ricardo Criado, Mayra Ianhez, Caio César Silva de Castro, Carolina Talhari, Paulo Müller Ramos, Hélio Amante Miot,
Tópico(s)Psoriasis: Treatment and Pathogenesis
ResumoJournal of the European Academy of Dermatology and VenereologyVolume 36, Issue 1 p. e1-e3 Letter to the Editor COVID-19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria P.R. Criado, P.R. Criado orcid.org/0000-0001-9785-6099 Centro Universitário Faculdade de Medicina do ABC and Alergoskin Alergia e Dermatologia, Santo André, BrazilSearch for more papers by this authorM. Ianhez, M. Ianhez Departamento de Medicina Tropical e Dermatologia da, Universidade Federal de Goiás (UFG), Goiânia, BrazilSearch for more papers by this authorC.C. Silva de Castro, C.C. Silva de Castro orcid.org/0000-0001-9767-5765 School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, BrazilSearch for more papers by this authorC. Talhari, C. Talhari Universidade do Estado do Amazonas, Manaus, BrazilSearch for more papers by this authorP.M. Ramos, P.M. Ramos orcid.org/0000-0002-1561-414X UNESP Medical School, Botucatu, BrazilSearch for more papers by this authorH.A. Miot, Corresponding Author H.A. Miot [email protected] orcid.org/0000-0002-2596-9294 UNESP Medical School, Botucatu, Brazil *Correspondence: H. Miot. E-mail: [email protected]Search for more papers by this author P.R. Criado, P.R. Criado orcid.org/0000-0001-9785-6099 Centro Universitário Faculdade de Medicina do ABC and Alergoskin Alergia e Dermatologia, Santo André, BrazilSearch for more papers by this authorM. Ianhez, M. Ianhez Departamento de Medicina Tropical e Dermatologia da, Universidade Federal de Goiás (UFG), Goiânia, BrazilSearch for more papers by this authorC.C. Silva de Castro, C.C. Silva de Castro orcid.org/0000-0001-9767-5765 School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, BrazilSearch for more papers by this authorC. Talhari, C. Talhari Universidade do Estado do Amazonas, Manaus, BrazilSearch for more papers by this authorP.M. Ramos, P.M. Ramos orcid.org/0000-0002-1561-414X UNESP Medical School, Botucatu, BrazilSearch for more papers by this authorH.A. Miot, Corresponding Author H.A. Miot [email protected] orcid.org/0000-0002-2596-9294 UNESP Medical School, Botucatu, Brazil *Correspondence: H. Miot. E-mail: [email protected]Search for more papers by this author First published: 06 September 2021 https://doi.org/10.1111/jdv.17635Citations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Genovese G, Moltrasio C, Berti E, Marzano AV. Skin manifestations associated with COVID-19: current knowledge and future perspectives. Dermatology 2021; 237: 1–12. 10.1159/000512932 CASPubMedWeb of Science®Google Scholar 2Marzano AV, Genovese G, Moltrasio C et al. The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicenter study of 200 adult patients. J Am Acad Dermatol 2021; 84: 1356–1363. 10.1016/j.jaad.2021.01.023 CASPubMedWeb of Science®Google Scholar 3Miot HA, Ianhez M, Muller RP. Self-reported cutaneous manifestations in 1429 Brazilian COVID-19-infected patients. J Eur Acad Dermatol Venereol 2021; 35: e172–e173. 10.1111/jdv.17024 CASPubMedWeb of Science®Google Scholar 4Patsatsi A, Kyriakou A. Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence? Clin Dermatol 2021; 39: 52–55. 10.1016/j.clindermatol.2020.12.012 PubMedWeb of Science®Google Scholar 5Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers 2018; 4: 1. 10.1038/s41572-018-0001-z PubMedWeb of Science®Google Scholar 6Donlan AN, Sutherland TE, Marie C et al. IL-13 is a driver of COVID-19 severity. JCI Insight 2021; 6: e150107. https://doi.org/10.1172/jci.insight.150107 PubMedWeb of Science®Google Scholar 7Kartal SP, Celik G, Yilmaz O et al. The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey. J Dermatolog Treat 2021; 32: 1–8. http://doi.org/10.1080/09546634.2021.1927947 10.1080/09546634.2021.1927947 PubMedWeb of Science®Google Scholar 8Wang J, Jiang M, Chen X, Montaner LJ. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol 2020; 108: 17–41. 10.1002/JLB.3COVR0520-272R CASPubMedWeb of Science®Google Scholar 9Gregório P, da Cunha RS, Biagini G et al. Chloroquine may induce endothelial injury through lysosomal dysfunction and oxidative stress. Toxicol Appl Pharmacol 2021; 414: 115412. 10.1016/j.taap.2021.115412 CASPubMedWeb of Science®Google Scholar 10Shen WX, Luo RC, Wang JQ, Chen ZS. Features of cytokine storm identified by distinguishing clinical manifestations in COVID-19. Front Public Health 2021; 9: 671788. 10.3389/fpubh.2021.671788 PubMedWeb of Science®Google Scholar Citing Literature Volume36, Issue1January 2022Pages e1-e3 This article also appears in:JEADV COVID-19 articles ReferencesRelatedInformation
Referência(s)